Chinese herbal compound to undergo trial for effects on liver cancer

- Last updated on GMT

Related tags: Liver cancer, Clinical trial

A study to investigate the effect of a chinese herb formula on
liver cancer is to be carried out at the Memorial Sloan-Kettering
Cancer Center, in New York.The Japanese compund, called
Sho-Saiko-to, is made up of seven Chinese herbs and is manufactured
by Honso Pharmaceutical Company, headquartered in Nagoya Japan.

A study to investigate the effect of a Chinese herb formula on liver cancer is to be carried out at the Memorial Sloan-Kettering Cancer Center in New York.

The Japanese compound, called Sho-Saiko-to, is made up of seven Chinese herbs and is manufactured by Honso Pharmaceutical Company, headquartered in Nagoya, Japan.

Liver cancer has a low success rate when treated but previous Japanese research on Sho-saiko-to has demonstrated its hepatoprotective, antiproliferative and immunostimulant effects in vitro.

In a randomised trial, cirrhotic patients receiving Sho-saiko-to had a lower incidence of developing HCC and a greater survival rate compared to those given a placebo. Honso claims that there is sufficient clinical evidence on Sho-saiko-to, especially with respect to dosage, to warrant a Phase II trial. The drug has so far shown capability primarily to inhibit tumour proliferation rather than to kill tumour cells.

The trial has been approved by the Food and Drug Administration (FDA).

Patients scheduled for ablative therapy will be assessed for eligibility and administered 7.5g of granular extract per day of Sho-saiko-to. The outcome used to power the trial is survival at 15 months, the median survival of a historical cohort. For purposes of secondary analyses, liver function, alpha-fetoprotein and intervention-free survival will be compared between the treated cohort and historical data.

The patients, approximately 80 in number, will be treated over a two year period, and then their progress followed for another year.

Related topics: Research, Suppliers, Botanicals

Related news

Related products

show more

The Ingredients Show 2019 NEC Birmingham

The Ingredients Show 2019 NEC Birmingham

William Reed | 01-Jan-2019 | Product Brochure

We’ve been bringing food and drink markets together for over 150 years. And the drive to
inform and serve our sectors that fuelled the launch of...

Indena’s approach in supporting sport nutrition

Indena’s approach in supporting sport nutrition

Indena: the botanical ingredient of Health Food industry | 22-Nov-2018 | Technical / White Paper

Edible plants confirm to be a paramount source of precious substances able to help in maintaining the overall wellbeing and complement the nutrition of...

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

LEHVOSS Nutrition– Gee Lawson | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

Decoding the Six Pathways of Ageing

Decoding the Six Pathways of Ageing

Gencor | 04-Oct-2018 | Technical / White Paper

The desire to extend lifespan has been around since the beginning of time and with the growing ageing population, more and more research is being conducted...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars